Additionally, it was found that the decrease in p-STAT3 expression level in the BY4008 treated group was more apparent than BY4003 treated group, which showed that BY4008 had strong inhibitory effects on p-STAT3 as compared with BY4003 in GBM cells. The gene discussed is STAT3; the disease is glioblastoma.